Please login to the form below

Not currently logged in

Hospira’s oncology drug approved by FDA

Hospira gains approval from the FDA for new oncology drug, gemcitabine injection

The US Food and Drug Administration (FDA) has approved a new oncology drug by Hospira.

The approval was for gemcitabine injection, a solution form of the drug. The company says that this solution form reduces preparation time and gives the medical community “access to a lower-cost, more convenient offering” of the oncology drug. 

Hospira is hoping to launch the product by early September, and will be the first company to offer gemcitabine in a solution formulation for the US market. 

The concentration of the solution is the same as the reconstituted strength of the currently available “freeze-dried” form, but will eliminate the need for reconstitution, thus improving work flow, according to the company.

Hospira hopes that it will also improve pharmacist convenience and handling safety. 

8th August 2011


Featured jobs

Subscribe to our email news alerts


Add my company
An agency called Owen

We’re an independent brand and marketing agency that believes our DNA is a little different from others. * A respectful,...

Latest intelligence

A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018